Sequestration hits front-line genetics research

The following is an edited excerpt.

Of all the blinkered buzz-saw cuts in this year’s $85 billion spending sequestration, perhaps none is as counterproductive — or as flat-out boneheaded — as the one now hitting medical research under way in a refurbished industrial expanse of central St. Louis.

Sequester cuts to the rapidly developing process of turning genetic research into a major 21st-century industry — and saving lives and health care costs — are the equivalent of trying to build the Interstate Highway System with no ramps or the transcontinental railroad without the final miles in the middle.

Read the full article here: Sequestration Stupidity Is Genetic, Hitting Front-Line Medical Research

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.